BNTX
Biontech Se
$98.74
Earnings Summary
Revenue | $895.3Mn |
Net Profits | $160.6Mn |
Net Profit Margins | 17.94% |
Highlights
Biontech Se’s revenue fell -74.13% since last year same period to $895.3Mn in the Q3 2023. On a quarterly growth basis, Biontech Se has generated 433.87% jump in its revenue since last 3-months.
Biontech Se’s net profit fell -91% since last year same period to $160.6Mn in the Q3 2023. On a quarterly growth basis, Biontech Se has generated 184.35% jump in its net profits since last 3-months.
Biontech Se’s net profit margin fell -65.22% since last year same period to 17.94% in the Q3 2023. On a quarterly growth basis, Biontech Se has generated 115.8% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Biontech Se post its latest quarter earnings
EPS Estimate Current Quarter | 2.77 |
EPS Estimate Current Year | 2.77 |
Highlights
Biontech Se’s earning per share (EPS) estimates for the current quarter stand at 2.77 - a 2870% jump from last quarter’s estimates.
Biontech Se’s earning per share (EPS) estimates for the current year stand at 2.77.
Key Ratios
Key ratios of the Biontech Se post its Q3 2023 earnings
Earning Per Share (EPS) | 0.67 |
Highlights
Biontech Se’s earning per share (EPS) fell -90.4% since last year same period to 0.67 in the Q3 2023. This indicates that the Biontech Se has generated -90.4% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-08 | 0.14 | 2.05 | 1364.29% |
2023-11-06 | -0.1 | 0.67 | 770% |
2023-08-07 | -0.96 | -0.79 | 17.71% |
₹0 US Stocks a/c Opening Fee